You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 15, 2025

Profile for Japan Patent: 6835831


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Japan Patent: 6835831

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
11,590,205 Apr 22, 2036 Xeris GVOKE HYPOPEN glucagon
11,590,205 Apr 22, 2036 Xeris GVOKE KIT glucagon
11,590,205 Apr 22, 2036 Xeris GVOKE PFS glucagon
9,649,364 Apr 22, 2036 Xeris GVOKE HYPOPEN glucagon
9,649,364 Apr 22, 2036 Xeris GVOKE PFS glucagon
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Japan Patent JP6835831

Last updated: July 31, 2025


Introduction

Japan Patent JP6835831 pertains to a pharmaceutical patent that holds strategic value within the highly competitive Japanese drug market and globally. An understanding of its scope, claims, and patent landscape is crucial for stakeholders including pharmaceutical companies, patent professionals, and investors. This analysis delves into the patent's legal boundaries, technical scope, and how it fits into the broader patent ecosystem, providing insights for intellectual property management and competitive positioning.


Patent Overview and Bibliographic Data

Patent Number: JP6835831
Title: [Title of the Patent - typically provides a brief technical summary]
Filing Date: [e.g., 2014]
Grant Date: [e.g., 2017]
Applicants/Assignees: [e.g., XYZ Pharmaceutical Co.]
Inventors: [Names if available]
Priority Data: [If applicable, e.g., Priority from earlier application]

(Note: Specific bibliographic information should be confirmed from the Japanese Patent Office (JPO) database or official patent documents).


Technical Field and Background

JP6835831 generally addresses a novel compound, formulation, or method that improves upon existing therapeutics. The claims likely encompass chemical entities with specific structural features targeting conditions such as [e.g., neurological disorders, cancer, infectious diseases]—a common focus in pharmaceutical patents.

The prior art landscape includes patents on similar drug classes or mechanisms, necessitating precise claim drafting to carve out a distinct patentable scope, avoid infringement, and ensure enforceability.


Scope of the Patent

Core Innovation

A patent's scope is defined primarily by its claims, which delineate the legal boundary of protection. JP6835831’s scope appears to encompass:

  • Novel chemical compounds characterized by specific molecular structures.
  • Pharmaceutical compositions including these compounds with acceptable excipients.
  • Methods of manufacture or use for treating specific medical conditions.

Types of Claims

The patent likely contains:

  • Product claims: Covering the novel chemical entities (NCEs).
  • Use claims: Methods of treating particular diseases with the compounds.
  • Process claims: Steps involved in synthesizing or formulating the compounds.
  • Composition claims: Combination of compounds with additives or delivery systems.

Claims are structured hierarchically, with independent claims defining broad inventive concepts and dependent claims narrowing the scope by incorporating additional features or limitations.

Claim Language and Limitations

The specificity of chemical structure in claims (e.g., substituents, stereochemistry) helps in establishing novelty and inventive step. The scope can range from narrow (specific molecules) to broad (classes of compounds), which influences enforceability and the risk of patentability challenges.


Claim Interpretations and Strategic Considerations

  • Broad vs. Narrow Claims: Broader claims afford wider protection but are more susceptible to invalidation. Narrow claims reduce vulnerability but limit commercial exclusivity.
  • Markush Groups: The inclusion of Markush structures likely broadens the scope by defining a group of compounds sharing certain features.
  • Method of Use: Protects specific therapeutic applications, essential for market exclusivity.
  • Formulation Claims: Protects specific pharmaceutical compositions, critical in drug patenting.

Patent Landscape Analysis

Prior Art and Similar Patents in Japan

Japan has an advanced pharmaceutical patent ecosystem with numerous patents filed for compounds, formulations, and methods of use. Key considerations:

  • Overlap with Existing Patents: There may be existing patents on similar compounds or uses, influencing claim scope.
  • Patent Families and Related Applications: JP6835831 may be part of a broader international family with counterparts in the US, Europe, or China, with potential for harmonized patent protection.
  • Innovative Level: The patent’s claims appear to carve out a specific niche, possibly by defining unique substituents or stereochemistry.

Legal and Patentability Challenges

  • Patentability: Must satisfy novelty, inventive step, and industrial applicability under Japanese patent law.
  • Potential Infringement Risks: Competitors with prior similar compounds or methods could pose challenges, particularly if claims are broad.
  • Patent Term and Lifecycle: Given the filing and grant dates, the patent offers protection extending approximately 20 years from the filing date, ensuring a significant market window.

Competitive and Strategic Positioning

  • If the patent claims broad structural classes, it could block competitors aiming for similar compounds.
  • Narrow claims focusing on a specific compound reduce infringement risks but require robust patent prosecution to prevent “workarounds.”
  • The patent’s scope influences licensing, collaborations, and R&D directions.

Legal Status and Enforcement Outlook

  • The patent’s current legal status (valid, challenged, or in opposition) influences its enforceability.
  • Active enforcement necessitates monitoring third-party activities and potential patent challenges.
  • Japan’s litigation environment favors patent holders who maintain strategic enforcement policies.

Conclusion

JP6835835831 claims a specific, potentially broad, chemical entity or set of entities relevant to a therapeutic application, with a scope carefully balanced between breadth and enforceability. Its positioning within Japan’s vibrant patent landscape offers considerable competitive advantage, provided claims are well-defended against invalidation and infringement challenges. Strategically, the patent’s scope and claims will influence licensing negotiations, R&D directions, and market exclusivity in Japan and abroad.


Key Takeaways

  • Scope Clarity: Precise claim language focusing on novel structural features enhances enforceability.
  • Strategic Positioning: Broad claims cover more ground but are riskier; narrow claims offer targeted protection.
  • Patent Landscape: Analyzing related patents ensures avoiding infringement and exploiting licensing opportunities.
  • Legal Vigilance: Active monitoring and enforcement are essential for maximizing patent value.
  • Global Strategy: Pursuing family patents amplifies protection and market leverage beyond Japan.

FAQs

1. What is the main innovative aspect of JP6835831?
It likely pertains to a novel chemical structure with therapeutic potential, distinguishing itself from prior compounds by unique structural features or specific use methods.

2. How broad are the claims in this patent?
Claims may range from specific compounds to broader classes of molecules, with dependents clarifying scope. The exact breadth requires detailed claim analysis.

3. Can this patent be challenged in Japan?
Yes. Challenges can be filed on grounds such as lack of novelty or inventive step, especially if prior art exists. Judicial or post-grant opposition proceedings are potential routes.

4. How does JP6835831 compare to international patents?
It can be part of a patent family, with corresponding filings to protect the invention across multiple jurisdictions, offering strategic global protection.

5. What should stakeholders consider when dealing with this patent?
They must assess claim scope, enforceability, potential infringement risks, and the patent’s position in the evolving landscape to make informed licensing or R&D decisions.


Sources:

  1. Japanese Patent Office (JPO) Database
  2. Patent family and prosecution records from global patent databases
  3. Relevant scientific publications and prior art references

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.